The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Bronchodilator-Global Market Insights and Sales Trends 2025
Synopsis
The global Bronchodilator market size is expected to reach US$ 42270 million by 2029, growing at a CAGR of 4.4% from 2023 to 2029. The market is mainly driven by the significant applications of Bronchodilator in various end use industries. The expanding demands from the Asthma, Chronic Obstructive Pulmonary Disease and Others,, are propelling Bronchodilator market. Short-acting Bronchodilator, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Long-acting Bronchodilator segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Bronchodilator market, driven by demand from China, the second largest economy with some signs of stabilising, the Bronchodilator market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Bronchodilator, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Bronchodilator market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Bronchodilator market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Bronchodilator sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Bronchodilator covered in this report include GlaxoSmithKline, Roche, AstraZeneca, Boehringer Ingelheim, Amgen, Kissei Pharmaceutical, Mitsubishi Tanabe Pharma, Sanofi and Theron Pharmaceuticals, etc.
The global Bronchodilator market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GlaxoSmithKline
Roche
AstraZeneca
Boehringer Ingelheim
Amgen
Kissei Pharmaceutical
Mitsubishi Tanabe Pharma
Sanofi
Theron Pharmaceuticals
Array BioPharma
Kyowa Hakko Kirin
Verona Pharma
Nycomed Pharma
Global Bronchodilator market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Bronchodilator market, Segment by Type:
Short-acting Bronchodilator
Long-acting Bronchodilator
Global Bronchodilator market, by Application
Asthma
Chronic Obstructive Pulmonary Disease
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Bronchodilator manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Bronchodilator in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global Bronchodilator market size is expected to reach US$ 42270 million by 2029, growing at a CAGR of 4.4% from 2023 to 2029. The market is mainly driven by the significant applications of Bronchodilator in various end use industries. The expanding demands from the Asthma, Chronic Obstructive Pulmonary Disease and Others,, are propelling Bronchodilator market. Short-acting Bronchodilator, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Long-acting Bronchodilator segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Bronchodilator market, driven by demand from China, the second largest economy with some signs of stabilising, the Bronchodilator market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Bronchodilator, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Bronchodilator market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Bronchodilator market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Bronchodilator sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Bronchodilator covered in this report include GlaxoSmithKline, Roche, AstraZeneca, Boehringer Ingelheim, Amgen, Kissei Pharmaceutical, Mitsubishi Tanabe Pharma, Sanofi and Theron Pharmaceuticals, etc.
The global Bronchodilator market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GlaxoSmithKline
Roche
AstraZeneca
Boehringer Ingelheim
Amgen
Kissei Pharmaceutical
Mitsubishi Tanabe Pharma
Sanofi
Theron Pharmaceuticals
Array BioPharma
Kyowa Hakko Kirin
Verona Pharma
Nycomed Pharma
Global Bronchodilator market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Bronchodilator market, Segment by Type:
Short-acting Bronchodilator
Long-acting Bronchodilator
Global Bronchodilator market, by Application
Asthma
Chronic Obstructive Pulmonary Disease
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Bronchodilator manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Bronchodilator in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Bronchodilator Market Overview
1.1 Bronchodilator Product Overview
1.2 Bronchodilator Market Segment by Type
1.2.1 Short-acting Bronchodilator
1.2.2 Long-acting Bronchodilator
1.3 Global Bronchodilator Market Size by Type
1.3.1 Global Bronchodilator Market Size Overview by Type (2018-2029)
1.3.2 Global Bronchodilator Historic Market Size Review by Type (2018-2023)
1.3.3 Global Bronchodilator Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Bronchodilator Sales Breakdown by Type (2018-2023)
1.4.2 Europe Bronchodilator Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Bronchodilator Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Bronchodilator Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Bronchodilator Sales Breakdown by Type (2018-2023)
2 Global Bronchodilator Market Competition by Company
2.1 Global Top Players by Bronchodilator Sales (2018-2023)
2.2 Global Top Players by Bronchodilator Revenue (2018-2023)
2.3 Global Top Players by Bronchodilator Price (2018-2023)
2.4 Global Top Manufacturers Bronchodilator Manufacturing Base Distribution, Sales Area, Product Type
2.5 Bronchodilator Market Competitive Situation and Trends
2.5.1 Bronchodilator Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Bronchodilator Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Bronchodilator as of 2022)
2.7 Date of Key Manufacturers Enter into Bronchodilator Market
2.8 Key Manufacturers Bronchodilator Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Bronchodilator Status and Outlook by Region
3.1 Global Bronchodilator Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Bronchodilator Historic Market Size by Region
3.2.1 Global Bronchodilator Sales in Volume by Region (2018-2023)
3.2.2 Global Bronchodilator Sales in Value by Region (2018-2023)
3.2.3 Global Bronchodilator Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Bronchodilator Forecasted Market Size by Region
3.3.1 Global Bronchodilator Sales in Volume by Region (2024-2029)
3.3.2 Global Bronchodilator Sales in Value by Region (2024-2029)
3.3.3 Global Bronchodilator Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Bronchodilator by Application
4.1 Bronchodilator Market Segment by Application
4.1.1 Asthma
4.1.2 Chronic Obstructive Pulmonary Disease
4.1.3 Others
4.2 Global Bronchodilator Market Size by Application
4.2.1 Global Bronchodilator Market Size Overview by Application (2018-2029)
4.2.2 Global Bronchodilator Historic Market Size Review by Application (2018-2023)
4.2.3 Global Bronchodilator Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Bronchodilator Sales Breakdown by Application (2018-2023)
4.3.2 Europe Bronchodilator Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Bronchodilator Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Bronchodilator Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Bronchodilator Sales Breakdown by Application (2018-2023)
5 North America Bronchodilator by Country
5.1 North America Bronchodilator Historic Market Size by Country
5.1.1 North America Bronchodilator Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Bronchodilator Sales in Volume by Country (2018-2023)
5.1.3 North America Bronchodilator Sales in Value by Country (2018-2023)
5.2 North America Bronchodilator Forecasted Market Size by Country
5.2.1 North America Bronchodilator Sales in Volume by Country (2024-2029)
5.2.2 North America Bronchodilator Sales in Value by Country (2024-2029)
6 Europe Bronchodilator by Country
6.1 Europe Bronchodilator Historic Market Size by Country
6.1.1 Europe Bronchodilator Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Bronchodilator Sales in Volume by Country (2018-2023)
6.1.3 Europe Bronchodilator Sales in Value by Country (2018-2023)
6.2 Europe Bronchodilator Forecasted Market Size by Country
6.2.1 Europe Bronchodilator Sales in Volume by Country (2024-2029)
6.2.2 Europe Bronchodilator Sales in Value by Country (2024-2029)
7 Asia-Pacific Bronchodilator by Region
7.1 Asia-Pacific Bronchodilator Historic Market Size by Region
7.1.1 Asia-Pacific Bronchodilator Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Bronchodilator Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Bronchodilator Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Bronchodilator Forecasted Market Size by Region
7.2.1 Asia-Pacific Bronchodilator Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Bronchodilator Sales in Value by Region (2024-2029)
8 Latin America Bronchodilator by Country
8.1 Latin America Bronchodilator Historic Market Size by Country
8.1.1 Latin America Bronchodilator Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Bronchodilator Sales in Volume by Country (2018-2023)
8.1.3 Latin America Bronchodilator Sales in Value by Country (2018-2023)
8.2 Latin America Bronchodilator Forecasted Market Size by Country
8.2.1 Latin America Bronchodilator Sales in Volume by Country (2024-2029)
8.2.2 Latin America Bronchodilator Sales in Value by Country (2024-2029)
9 Middle East and Africa Bronchodilator by Country
9.1 Middle East and Africa Bronchodilator Historic Market Size by Country
9.1.1 Middle East and Africa Bronchodilator Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Bronchodilator Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Bronchodilator Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Bronchodilator Forecasted Market Size by Country
9.2.1 Middle East and Africa Bronchodilator Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Bronchodilator Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 GlaxoSmithKline
10.1.1 GlaxoSmithKline Company Information
10.1.2 GlaxoSmithKline Introduction and Business Overview
10.1.3 GlaxoSmithKline Bronchodilator Sales, Revenue and Gross Margin (2018-2023)
10.1.4 GlaxoSmithKline Bronchodilator Products Offered
10.1.5 GlaxoSmithKline Recent Development
10.2 Roche
10.2.1 Roche Company Information
10.2.2 Roche Introduction and Business Overview
10.2.3 Roche Bronchodilator Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Roche Bronchodilator Products Offered
10.2.5 Roche Recent Development
10.3 AstraZeneca
10.3.1 AstraZeneca Company Information
10.3.2 AstraZeneca Introduction and Business Overview
10.3.3 AstraZeneca Bronchodilator Sales, Revenue and Gross Margin (2018-2023)
10.3.4 AstraZeneca Bronchodilator Products Offered
10.3.5 AstraZeneca Recent Development
10.4 Boehringer Ingelheim
10.4.1 Boehringer Ingelheim Company Information
10.4.2 Boehringer Ingelheim Introduction and Business Overview
10.4.3 Boehringer Ingelheim Bronchodilator Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Boehringer Ingelheim Bronchodilator Products Offered
10.4.5 Boehringer Ingelheim Recent Development
10.5 Amgen
10.5.1 Amgen Company Information
10.5.2 Amgen Introduction and Business Overview
10.5.3 Amgen Bronchodilator Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Amgen Bronchodilator Products Offered
10.5.5 Amgen Recent Development
10.6 Kissei Pharmaceutical
10.6.1 Kissei Pharmaceutical Company Information
10.6.2 Kissei Pharmaceutical Introduction and Business Overview
10.6.3 Kissei Pharmaceutical Bronchodilator Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Kissei Pharmaceutical Bronchodilator Products Offered
10.6.5 Kissei Pharmaceutical Recent Development
10.7 Mitsubishi Tanabe Pharma
10.7.1 Mitsubishi Tanabe Pharma Company Information
10.7.2 Mitsubishi Tanabe Pharma Introduction and Business Overview
10.7.3 Mitsubishi Tanabe Pharma Bronchodilator Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Mitsubishi Tanabe Pharma Bronchodilator Products Offered
10.7.5 Mitsubishi Tanabe Pharma Recent Development
10.8 Sanofi
10.8.1 Sanofi Company Information
10.8.2 Sanofi Introduction and Business Overview
10.8.3 Sanofi Bronchodilator Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Sanofi Bronchodilator Products Offered
10.8.5 Sanofi Recent Development
10.9 Theron Pharmaceuticals
10.9.1 Theron Pharmaceuticals Company Information
10.9.2 Theron Pharmaceuticals Introduction and Business Overview
10.9.3 Theron Pharmaceuticals Bronchodilator Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Theron Pharmaceuticals Bronchodilator Products Offered
10.9.5 Theron Pharmaceuticals Recent Development
10.10 Array BioPharma
10.10.1 Array BioPharma Company Information
10.10.2 Array BioPharma Introduction and Business Overview
10.10.3 Array BioPharma Bronchodilator Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Array BioPharma Bronchodilator Products Offered
10.10.5 Array BioPharma Recent Development
10.11 Kyowa Hakko Kirin
10.11.1 Kyowa Hakko Kirin Company Information
10.11.2 Kyowa Hakko Kirin Introduction and Business Overview
10.11.3 Kyowa Hakko Kirin Bronchodilator Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Kyowa Hakko Kirin Bronchodilator Products Offered
10.11.5 Kyowa Hakko Kirin Recent Development
10.12 Verona Pharma
10.12.1 Verona Pharma Company Information
10.12.2 Verona Pharma Introduction and Business Overview
10.12.3 Verona Pharma Bronchodilator Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Verona Pharma Bronchodilator Products Offered
10.12.5 Verona Pharma Recent Development
10.13 Nycomed Pharma
10.13.1 Nycomed Pharma Company Information
10.13.2 Nycomed Pharma Introduction and Business Overview
10.13.3 Nycomed Pharma Bronchodilator Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Nycomed Pharma Bronchodilator Products Offered
10.13.5 Nycomed Pharma Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Bronchodilator Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Bronchodilator Industrial Chain Analysis
11.4 Bronchodilator Market Dynamics
11.4.1 Bronchodilator Industry Trends
11.4.2 Bronchodilator Market Drivers
11.4.3 Bronchodilator Market Challenges
11.4.4 Bronchodilator Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Bronchodilator Distributors
12.3 Bronchodilator Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
